Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omalizumab in Work-Related Animal Induced Asthma
NCT00242359Phase 4Withdrawn
- Sponsor
- Bernstein Allergy Group and Clinical Research Center
- Start
- Nov 2005
- Primary completion
- Jan 2009
- Modality
- Monoclonal Antibodies
01
Overview
Phase 4, open-label, single-arm trial of omalizumab in asthma, sponsored by Bernstein Allergy Group and Clinical Research Center. Planned start Nov 2005; status: withdrawn.
02
Drugs
omalizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00242359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00242359.